The basal-like group was subsequently defined, using immunohistochemistry, as being ER- PR- ERBB2-, with tumor cells expressing at least one basal-myoepithelial marker such as KRT 5/6 or KRT 14 in association with EGFR or KIT [6,8,22]. The gene discussed is ERBB2; the disease is neoplasm.